BCE Pharma published study results on hazardous antineoplastic
drug surface contamination

BCE Pharma published study results on hazardous antineoplastic drug surface contamination in pharmacy and oncology clinics in Canadian hospitals.

 

Thank you to Dr. Regis Vaillancourt for presenting this research at the 80th FIP World Congress of Pharmacy and Pharmaceutical Sciences in September 2022 in Seville, Spain.